The independent source for health policy research, polling, and news.
5,141 - 5,160 of 15,455 Results
California legislators resume their work Monday after more than a month off. While the coronavirus pandemic has shifted the state’s priorities, many lawmakers say they still intend to push non-COVID health care bills to tax soda, ban vape flavors and more.
Because the public health system mostly operates in the background, it rarely gets the attention or funding it deserves ― until there’s a crisis.
KHN’s Julie Rovner joins a panel of journalists on “1A” to talk about promising results in a study of the drug remdesivir and other developments in the battle against the coronavirus.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
When you factor in population size, the U.S. is still behind.
Los Angeles County is providing thousands of coronavirus self-testing kits to its citizens, but public health officials are leery of the shortage of data on whether this easier method ― in which an individual swabs his or her own cheek ― is as reliable as a less comfortable but well-established technique.
The nursing schools at UCLA, UCSF and UC-Davis have joined hands in a new one-year online training program for mental health care as a surge of patients is expected due to the social isolation and economic impact of COVID-19.
The Supreme Court this week, in an 8-1 decision, ruled that insurers are due the roughly $12 billion that Congress several years ago tried to cut off in payments under the Affordable Care Act’s “risk corridors” provision. And while the COVID-19 pandemic continues to rage in many places around the country, states are starting to reopen their economies at the urging of President Donald Trump and over objections of public health officials. Caitlin Owens of Axios and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Carmen Heredia Rodriguez, who wrote the latest KHN-NPR “Bill of the Month” installment about COVID testing that should have been free but was not.
The volunteer medical providers at the Tree of Life Free Clinic in Tupelo, Mississippi, give crucial health care to the uninsured in the best of times, drawing crowds who line up for hours. Amid the current COVID pandemic, clinic staffers were advised to close. Instead, they chose to adapt — even without critical N95 masks to protect themselves — as the economic crisis intensifies the need for free care.
The Families First Coronavirus Response Act requires private insurers to pay for certain services related to coronavirus testing at no cost to the patient. But gaps in the protections expose patients to unexpected medical bills.
The U.S. government spent $36 billion computerizing health records, yet they’re of limited help in the COVID-19 crisis.
Increasing evidence suggests people who smoke are more likely to become severely ill and die from COVID-19 than nonsmokers. Some people are using that as inspiration to quit.
Repurposing one N95 mask 20 times is not the same as having 20 new ones.
Her doctor worried she had COVID-19 but couldn’t test her for it until she ruled out other things. That test cost a bundle.
Even while playing the role of quarantine enforcer for your teens and 20-somethings, recognize that they are as anxious and worried as you are — and with good reason.
Because high-end N95 masks are scarce, medical centers are using surgical masks that have been linked to considerably higher infection rates.
Gov. Gavin Newsom has asked lawmakers to pare down their legislative wish lists and focus on the state’s coronavirus response. But state Sen. Jim Beall plans to forge ahead with his mental health care proposals, including a measure to create a state mental health parity requirement.
As the coronavirus threatens the finances of thousands of hospitals, wealthy ones that can draw on millions — and even billions — of dollars in savings are in competition with near-insolvent hospitals for limited pots of financial relief.
With most nonemergency procedures shelved for now, many health insurers are expected to see profits in the near term, but the longer view of how the coronavirus will affect them is far more complicated and could well impact what people pay for coverage next year.
Public officials are putting high hopes on new blood tests as a means of determining who has developed antibodies to COVID-19, and with those antibodies, presumed immunity. But experts caution the tests are largely unreliable and the science is still catching up.
© 2026 KFF